VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 232,062,084
- Share change
- -1,929,174
- Total reported value
- $46,728,254,072
- Put/Call ratio
- 89%
- Price per share
- $201.63
- Number of holders
- 961
- Value change
- -$411,655,570
- Number of buys
- 490
- Number of sells
- 453
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
9.5%
|
24,244,113
|
$5,209,816,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
8%
|
20,415,711
|
$4,387,134,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.5%
|
16,549,876
|
$3,556,402,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
11,175,038
|
$2,401,404,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
4%
|
10,171,242
|
$2,185,698,000 | — | 31 Mar 2021 | |
| Capital World Investors |
13F
|
Company |
3.8%
|
9,657,475
|
$2,075,288,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.2%
|
8,086,364
|
$1,737,680,000 | — | 31 Mar 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.1%
|
7,858,607
|
$1,688,736,000 | — | 31 Mar 2021 | |
| Capital International Investors |
13F
|
Company |
2.4%
|
6,042,569
|
$1,298,481,000 | — | 31 Mar 2021 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.2%
|
5,521,210
|
$1,186,453,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.8%
|
4,508,809
|
$968,908,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
3,941,186
|
$844,607,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
3,206,300
|
$689,000,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
2,978,250
|
$639,996,000 | — | 31 Mar 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.1%
|
2,856,616
|
$613,858,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
2,743,391
|
$589,528,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
1%
|
2,637,526
|
$566,778,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.94%
|
2,400,284
|
$515,797,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.84%
|
2,148,665
|
$461,727,000 | — | 31 Mar 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.81%
|
2,069,519
|
$444,718,937 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.8%
|
2,039,039
|
$438,169,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.79%
|
2,008,913
|
$431,695,000 | — | 31 Mar 2021 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.78%
|
1,983,089
|
$426,146,000 | — | 31 Mar 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.75%
|
1,918,067
|
$412,162,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.68%
|
1,719,180
|
$369,435,000 | — | 31 Mar 2021 | |
| ARK Investment Management LLC |
13F
|
Company |
0.67%
|
1,719,046
|
$369,406,000 | — | 31 Mar 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.67%
|
1,708,397
|
$367,118,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
1,662,566
|
$357,268,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.58%
|
1,488,975
|
$319,966,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.58%
|
1,465,261
|
$314,870,000 | — | 31 Mar 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.55%
|
1,400,000
|
$300,846,000 | — | 31 Mar 2021 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.55%
|
1,396,827
|
$300,164,000 | — | 31 Mar 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.54%
|
1,376,704
|
$295,840,000 | — | 31 Mar 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.49%
|
1,254,233
|
$269,522,000 | — | 31 Mar 2021 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.49%
|
1,242,459
|
$266,992,000 | — | 31 Mar 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.48%
|
1,230,348
|
$264,391,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.48%
|
1,230,059
|
$264,328,000 | — | 31 Mar 2021 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.48%
|
1,227,475
|
$263,772,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.47%
|
1,206,425
|
$259,249,000 | — | 31 Mar 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.46%
|
1,163,677
|
$250,063,000 | — | 31 Mar 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.45%
|
1,135,900
|
$244,094,000 | — | 31 Mar 2021 | |
| APG Asset Management N.V. |
13F
|
Company |
0.49%
|
1,247,339
|
$228,061,000 | — | 31 Mar 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.39%
|
987,288
|
$212,158,000 | — | 31 Mar 2021 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.38%
|
969,069
|
$208,244,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.38%
|
968,589
|
$208,141,000 | — | 31 Mar 2021 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.36%
|
910,527
|
$195,226,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.36%
|
905,921
|
$194,673,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.35%
|
895,382
|
$192,407,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.35%
|
887,740
|
$190,766,000 | — | 31 Mar 2021 | |
| Manning & Napier Group, LLC |
13F
|
Company |
0.34%
|
858,216
|
$184,420,000 | — | 31 Mar 2021 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2021
As of 30 Jun 2021,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
961 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
232,062,084 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., FMR LLC, Clearbridge Investments, LLC, and Capital International Investors.
This page lists
963
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
983
Q2 2021 holders
961
Holder diff
-22
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.